Gossamer Bio, Inc. - Common Stock (GOSS)

CUSIP: 38341P102

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock
Shares outstanding
239,264,205
Total 13F shares
59,875,031
Share change
+1,069,256
Total reported value
$519,727,258
Put/Call ratio
37%
Price per share
$8.68
Number of holders
138
Value change
+$5,179,881
Number of buys
71
Number of sells
57

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 38341P102?
CUSIP 38341P102 identifies GOSS - Gossamer Bio, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of GOSS - Gossamer Bio, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
HHLR ADVISORS, LTD.
13F
Company
3.1%
7,420,974
$83,931,000 31 Dec 2021
13F
VANGUARD GROUP INC
13F
Company
2.3%
5,587,459
$63,193,000 31 Dec 2021
13F
BlackRock Finance, Inc.
13F
Company
2.3%
5,429,686
$61,409,000 31 Dec 2021
13F
STATE STREET CORP
13F
Company
1.4%
3,292,091
$37,234,000 31 Dec 2021
13F
Omega Fund Management, LLC
13F
Company
1.3%
3,164,835
$35,794,000 31 Dec 2021
13F
FEDERATED HERMES, INC.
13F
Company
1.2%
2,962,242
$33,503,000 31 Dec 2021
13F
Boxer Capital, LLC
13F
Company
1%
2,462,358
$27,849,000 31 Dec 2021
13F
Artal Group S.A.
13F
Company
0.99%
2,358,968
$26,680,000 31 Dec 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.78%
1,875,751
$21,214,000 31 Dec 2021
13F
EMERALD MUTUAL FUND ADVISERS TRUST
13F
Company
0.75%
1,805,305
$20,418,000 31 Dec 2021
13F
Palo Alto Investors LP
13F
Company
0.74%
1,772,950
$20,052,000 31 Dec 2021
13F
EMERALD ADVISERS, LLC
13F
Company
0.74%
1,770,919
$20,029,000 31 Dec 2021
13F
Octagon Capital Advisors LP
13F
Company
0.63%
1,513,138
$17,114,000 31 Dec 2021
13F
MORGAN STANLEY
13F
Company
0.51%
1,221,854
$13,820,000 31 Dec 2021
13F
Ikarian Capital, LLC
13F
Company
0.49%
1,166,933
$13,199,000 31 Dec 2021
13F
Kynam Capital Management, LP
13F
Company
0.42%
1,016,857
$11,501,000 31 Dec 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.42%
1,013,083
$11,457,000 31 Dec 2021
13F
Woodline Partners LP
13F
Company
0.41%
977,823
$11,059,000 31 Dec 2021
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.38%
908,432
$10,274,000 31 Dec 2021
13F
FMR LLC
13F
Company
0.37%
894,500
$10,117,000 31 Dec 2021
13F
NORGES BANK
13F
Company
0.3%
724,800
$8,197,000 31 Dec 2021
13F
ORBIMED ADVISORS LLC
13F
Company
0.29%
683,000
$7,725,000 31 Dec 2021
13F
NORTHERN TRUST CORP
13F
Company
0.25%
598,089
$6,764,000 31 Dec 2021
13F
MARSHALL WACE, LLP
13F
Company
0.24%
572,072
$6,471,000 31 Dec 2021
13F
Parkman Healthcare Partners LLC
13F
Company
0.23%
546,421
$6,180,000 31 Dec 2021
13F
Ally Bridge Group (NY) LLC
13F
Company
0.2%
475,000
$5,372,000 31 Dec 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.16%
390,505
$4,417,000 31 Dec 2021
13F
LORD, ABBETT & CO. LLC
13F
Company
0.16%
390,146
$4,413,000 31 Dec 2021
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.14%
332,251
$3,758,000 31 Dec 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.11%
265,200
$2,999,000 31 Dec 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.11%
253,646
$2,869,000 31 Dec 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.1%
244,088
$2,761,000 31 Dec 2021
13F
Bank of New York Mellon Corp
13F
Company
0.1%
228,196
$2,581,000 31 Dec 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.09%
208,892
$2,363,000 31 Dec 2021
13F
Cormorant Asset Management, LP
13F
Company
0.08%
198,382
$2,244,000 31 Dec 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.09%
206,954
$2,127,000 31 Dec 2021
13F
Rafferty Asset Management, LLC
13F
Company
0.08%
183,844
$2,079,000 31 Dec 2021
13F
Walleye Capital LLC
13F
Company
0.08%
181,624
$2,054,000 31 Dec 2021
13F
UBS Group AG
13F
Company
0.07%
165,428
$1,871,000 31 Dec 2021
13F
CITIGROUP INC
13F
Company
0.06%
152,785
$1,728,000 31 Dec 2021
13F
Ensign Peak Advisors, Inc
13F
Company
0.06%
151,166
$1,710,000 31 Dec 2021
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.05%
122,500
$1,385,000 31 Dec 2021
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
0.05%
119,843
$1,355,000 31 Dec 2021
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.05%
116,399
$1,316,000 31 Dec 2021
13F
Endurant Capital Management LP
13F
Company
0.05%
113,660
$1,285,000 31 Dec 2021
13F
MOORE CAPITAL MANAGEMENT, LP
13F
Company
0.05%
109,024
$1,233,000 31 Dec 2021
13F
Swiss National Bank
13F
Company
0.05%
108,800
$1,231,000 31 Dec 2021
13F
Birchview Capital, LP
13F
Company
0.04%
100,000
$1,131,000 31 Dec 2021
13F
RHUMBLINE ADVISERS
13F
Company
0.04%
91,264
$1,032,000 31 Dec 2021
13F
ALPS ADVISORS INC
13F
Company
0.04%
88,487
$1,001,000 31 Dec 2021
13F

Institutional Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q1 2022

As of 31 Mar 2022, Gossamer Bio, Inc. - Common Stock (GOSS) was held by 138 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 59,875,031 shares. The largest 10 holders included HHLR ADVISORS, LTD., VANGUARD GROUP INC, BlackRock Inc., FEDERATED HERMES, INC., STATE STREET CORP, Omega Fund Management, LLC, Octagon Capital Advisors LP, BOXER CAPITAL, LLC, Artal Group S.A., and CITADEL ADVISORS LLC. This page lists 138 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders
129
Q1 2022 holders
138
Holder diff
9
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 Value $ Q1 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.